Given the association between FSH and various cancers, there is interest in using FSH levels as a biomarker for cancer diagnosis and prognosis. Elevated FSH levels could potentially indicate the presence of reproductive organ cancers and help monitor the effectiveness of treatment. However, more research is needed to validate FSH as a reliable biomarker in clinical settings.
